Market Cap 8.08B
Revenue (ttm) 2.09B
Net Income (ttm) -304.90M
EPS (ttm) N/A
PE Ratio 26.92
Forward PE 27.81
Profit Margin -14.56%
Debt to Equity Ratio 0.57
Volume 336,900
Avg Vol 644,262
Day's Range N/A - N/A
Shares Out 54.33M
Stochastic %K 42%
Beta 1.28
Analysts Strong Sell
Price Target $187.57

Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemog...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 297 7000
Fax: 949 297 7001
Address:
52 Discovery, Irvine, United States
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 6:38 PM
Enter: $MASI NOV 21 2025 $150 CALLS Buy in Price: $8.28 - $9.60 Take Profit: $10.93 Stop Bleeding: $7.29 ROI Potential: 32% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Wigglyick
Wigglyick Oct. 15 at 2:32 PM
$MASI Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions.
0 · Reply
11thestate
11thestate Oct. 9 at 11:27 PM
$MASI is accepting claims for a $33.75M settlement to resolve allegations it misled investors about its ability to sustain growth following its $1B acquisition of Sound United. If you bought $MASI between May 4, 2022, and August 8, 2023, you still can file for payment here: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=10092025_1
0 · Reply
IronFade
IronFade Oct. 5 at 11:11 AM
$MASI Healthcare equipment consistency. Steady uptrend intact. Low volatility institutional holding. Relative strength notable.
0 · Reply
TalkMarkets
TalkMarkets Sep. 27 at 3:20 AM
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI $MASI $COLL Also $ALC $SONVY https://talkmarkets.com/content/stocks--equities/dont-overlook-these-2-highly-ranked-medical-stocks-coll-masi?post=525107
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 7:40 AM
Enter: $MASI OCT 17 2025 $145 CALLS Buy in Price: $4.90 - $5.75 Take Profit: $10.18 Stop Bleeding: $5.06 ROI Potential: 77% Exit Within: 152 Minutes https://moneygroup.us/alerts
0 · Reply
11thestate
11thestate Sep. 25 at 2:24 PM
$MASI is accepting claims for a $33.75M settlement to resolve allegations it misled investors about its ability to sustain growth following its $1B acquisition of Sound United. If you bought $MASI between May 4, 2022, and August 8, 2023, you can file for payment here: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09252025_1
0 · Reply
ZacksResearch
ZacksResearch Sep. 25 at 1:52 PM
$MASI sharpens focus with strategic divestiture! 🎯 📈 Sold Sound United to HARMAN to concentrate on healthcare 🔄 Proceeds earmarked for share repurchases, boosting shareholder value 💡 Focus on intelligent monitoring & wearable tech innovation MASI’s shares have lost 15% year-to-date, but see why it could be a pure-play medtech leader 👉 https://www.zacks.com/stock/news/2756914/masimo-completes-divestment-of-consumer-audio-business-to-harman?cid=sm-stocktwits-2-2756914-body-14080&ADID=SYND_STOCKTWITS_TWEET_2_2756914_BODY_14080
0 · Reply
ZacksResearch
ZacksResearch Sep. 25 at 12:52 PM
$MASI sharpening the blade 🔪—core healthcare focus just got a whole lot clearer. By completing the sale of Sound United to HARMAN, the company is boosting margins and freeing up capital for buybacks. See the full breakdown here 👉 https://www.zacks.com/stock/news/2756914/masimo-completes-divestment-of-consumer-audio-business-to-harman?cid=sm-stocktwits-2-2756914-teaser-14079&ADID=SYND_STOCKTWITS_TWEET_2_2756914_TEASER_14079
0 · Reply
RunnerSignals
RunnerSignals Sep. 19 at 8:53 PM
More Upgrade Action Today $BSX $CVS $MASI $HTGC $WAY all caught fresh upgrades https://stocksrunner.com/news/2025-09-19-stock-upgrades-today-signal-strong-buy-opportunities-ahead
0 · Reply
Latest News on MASI
Masimo to Host Investor Day on December 3, 2025

Oct 9, 2025, 9:00 AM EDT - 16 days ago

Masimo to Host Investor Day on December 3, 2025


Masimo to Present in the Wells Fargo Healthcare Conference

Aug 28, 2025, 9:00 AM EDT - 2 months ago

Masimo to Present in the Wells Fargo Healthcare Conference


Masimo sues US Customs over approval of Apple Watch imports

Aug 20, 2025, 6:52 PM EDT - 2 months ago

Masimo sues US Customs over approval of Apple Watch imports

AAPL


Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:03 PM EDT - 2 months ago

Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript


Masimo Reports Second Quarter 2025 Results

Aug 5, 2025, 4:05 PM EDT - 2 months ago

Masimo Reports Second Quarter 2025 Results


Masimo to Present in the Jefferies Global Healthcare Conference

May 27, 2025, 9:00 AM EDT - 5 months ago

Masimo to Present in the Jefferies Global Healthcare Conference


Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript

May 6, 2025, 10:15 PM EDT - 6 months ago

Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript


Masimo Reports First Quarter 2025 Results

May 6, 2025, 4:10 PM EDT - 6 months ago

Masimo Reports First Quarter 2025 Results


Masimo to Sell Consumer Audio Business to HARMAN International

May 6, 2025, 4:10 PM EDT - 6 months ago

Masimo to Sell Consumer Audio Business to HARMAN International


Masimo to Sell Audio Business to Harman After Investor Outrage

May 6, 2025, 4:00 PM EDT - 6 months ago

Masimo to Sell Audio Business to Harman After Investor Outrage


Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 6:02 PM EST - 8 months ago

Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript


Masimo Taps Katie Szyman as Permanent CEO

Jan 21, 2025, 5:22 PM EST - 9 months ago

Masimo Taps Katie Szyman as Permanent CEO


Masimo names Becton Dickinson's Katie Szyman CEO

Jan 21, 2025, 4:56 PM EST - 9 months ago

Masimo names Becton Dickinson's Katie Szyman CEO


Masimo Announces Leadership Transition

Jan 21, 2025, 4:00 PM EST - 9 months ago

Masimo Announces Leadership Transition


Masimo to Present in Stifel 2024 Healthcare Conference

Nov 13, 2024, 9:00 AM EST - 1 year ago

Masimo to Present in Stifel 2024 Healthcare Conference


Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:57 PM EST - 1 year ago

Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript


Masimo Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 4:05 PM EST - 1 year ago

Masimo Reports Third Quarter 2024 Financial Results


Masimo Terminates Founder Kiani as CEO

Oct 29, 2024, 5:57 PM EDT - 1 year ago

Masimo Terminates Founder Kiani as CEO


Apple wins $250 from Masimo in watch patent trial

Oct 26, 2024, 3:53 PM EDT - 1 year ago

Apple wins $250 from Masimo in watch patent trial

AAPL


MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 6:38 PM
Enter: $MASI NOV 21 2025 $150 CALLS Buy in Price: $8.28 - $9.60 Take Profit: $10.93 Stop Bleeding: $7.29 ROI Potential: 32% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Wigglyick
Wigglyick Oct. 15 at 2:32 PM
$MASI Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions.
0 · Reply
11thestate
11thestate Oct. 9 at 11:27 PM
$MASI is accepting claims for a $33.75M settlement to resolve allegations it misled investors about its ability to sustain growth following its $1B acquisition of Sound United. If you bought $MASI between May 4, 2022, and August 8, 2023, you still can file for payment here: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=10092025_1
0 · Reply
IronFade
IronFade Oct. 5 at 11:11 AM
$MASI Healthcare equipment consistency. Steady uptrend intact. Low volatility institutional holding. Relative strength notable.
0 · Reply
TalkMarkets
TalkMarkets Sep. 27 at 3:20 AM
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI $MASI $COLL Also $ALC $SONVY https://talkmarkets.com/content/stocks--equities/dont-overlook-these-2-highly-ranked-medical-stocks-coll-masi?post=525107
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 7:40 AM
Enter: $MASI OCT 17 2025 $145 CALLS Buy in Price: $4.90 - $5.75 Take Profit: $10.18 Stop Bleeding: $5.06 ROI Potential: 77% Exit Within: 152 Minutes https://moneygroup.us/alerts
0 · Reply
11thestate
11thestate Sep. 25 at 2:24 PM
$MASI is accepting claims for a $33.75M settlement to resolve allegations it misled investors about its ability to sustain growth following its $1B acquisition of Sound United. If you bought $MASI between May 4, 2022, and August 8, 2023, you can file for payment here: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09252025_1
0 · Reply
ZacksResearch
ZacksResearch Sep. 25 at 1:52 PM
$MASI sharpens focus with strategic divestiture! 🎯 📈 Sold Sound United to HARMAN to concentrate on healthcare 🔄 Proceeds earmarked for share repurchases, boosting shareholder value 💡 Focus on intelligent monitoring & wearable tech innovation MASI’s shares have lost 15% year-to-date, but see why it could be a pure-play medtech leader 👉 https://www.zacks.com/stock/news/2756914/masimo-completes-divestment-of-consumer-audio-business-to-harman?cid=sm-stocktwits-2-2756914-body-14080&ADID=SYND_STOCKTWITS_TWEET_2_2756914_BODY_14080
0 · Reply
ZacksResearch
ZacksResearch Sep. 25 at 12:52 PM
$MASI sharpening the blade 🔪—core healthcare focus just got a whole lot clearer. By completing the sale of Sound United to HARMAN, the company is boosting margins and freeing up capital for buybacks. See the full breakdown here 👉 https://www.zacks.com/stock/news/2756914/masimo-completes-divestment-of-consumer-audio-business-to-harman?cid=sm-stocktwits-2-2756914-teaser-14079&ADID=SYND_STOCKTWITS_TWEET_2_2756914_TEASER_14079
0 · Reply
RunnerSignals
RunnerSignals Sep. 19 at 8:53 PM
More Upgrade Action Today $BSX $CVS $MASI $HTGC $WAY all caught fresh upgrades https://stocksrunner.com/news/2025-09-19-stock-upgrades-today-signal-strong-buy-opportunities-ahead
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 19 at 5:32 PM
Enter: $MASI OCT 17 2025 $145 CALLS Buy in Price: $5.40 - $5.75 Take Profit: $11.56 Stop Bleeding: $5.06 ROI Potential: 101% Exit Within: 147 Minutes https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Sep. 11 at 1:12 PM
BTIG has adjusted their stance on Masimo ( $MASI ), setting the rating to Buy with a target price of 198.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 12:04 PM
$MASI Excellent article that nails exactly where MASI stands right now. So if you want to update your MASI knowledge or get acquainted with MASI, this is a must read. https://beyondspx.com/quote/MASI/analysis/precision-profit-masimo-s-strategic-recalibration-for-healthcare-dominance-nasdaq-masi
0 · Reply
11thestate
11thestate Sep. 8 at 3:20 PM
Took a hit on $MASI? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09082025_1 #MASI
0 · Reply
11thestate
11thestate Aug. 28 at 12:12 PM
$MASI has agreed to settle $33,750,000 with investors to resolve claims that it misled the market about its ability to sustain growth following its $1 billion acquisition of Sound United. Who’s eligible? Anyone who purchased $MASI shares between May 4, 2022, and August 8, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $1.30 — but if only ~25% of eligible investors file, the effective payout could increase to $5.20. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08282025_1
0 · Reply
Estimize
Estimize Aug. 27 at 1:00 PM
Wall St is expecting 1.20 EPS for $MASI Q3 [Reporting 11/11 AMC] http://www.estimize.com/intro/masi?chart=historical&metric_name=eps&utm_co
0 · Reply
DonCorleone77
DonCorleone77 Aug. 21 at 10:17 AM
$MASI $AAPL From Bloomberg Law: "Masimo Sues Customs Over Apple Watch’s Restored Oxygen Tool" https://news.bloomberglaw.com/daily-labor-report/masimo-sues-us-customs-over-apple-restoring-watchs-oxygen-tool
0 · Reply
smartkarma
smartkarma Aug. 21 at 6:06 AM
$MASI | Masimo Corporation Unveils Next-Gen Root Monitor; Can Its Innovations Help Grap A Larger Pie Of The Market? "Masimo Corporation’s second quarter of 2025 presents a mixed yet interesting picture for potential investors, focusing predominantly on the..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/masimo-corporation-unveils-next-gen-root-monitor-can-its-innovations-help-grap-a-larger-pie-of-the-market
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 21 at 3:01 AM
Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature $MASI $AAPL https://stocktwits.com/news/equity/markets/apple-s-watch-war-heats-up-masimo-takes-customs-to-court-over-blood-oxygen-feature/chsSKuFRdL7
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 6:13 PM
$MASI shares lost 4.6% following FDA clearance for expanded O3 Regional Oximetry indications — a buying opportunity? 🤔 FDA nod for expanded O3 Regional Oximetry indications could drive growth in high-margin brain monitoring, yet shares are down 11.2% year-to-date, underperforming the industry’s 7.6% decline. Discover what's next for Masimo 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-body-8701&ADID=SYND_STOCKTWITS_TWEET_2_2740478_BODY_8701
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 5:13 PM
$MASI dips on FDA win? 🤔 The company just got clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups — yet shares are trading lower. See the full bull/bear setup here 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-teaser-8700&ADID=SYND_STOCKTWITS_TWEET_2_2740478_TEASER_8700
0 · Reply
11thestate
11thestate Aug. 18 at 8:51 PM
Took a hit on $MASI? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08182025_1 #MASI
0 · Reply